Skip to main content
Back
Watch Compare

VACCINEX, INC.

Data quality: 100%
VCNX
OTC Manufacturing Chemicals
$1.00
$0.00 (0.00%)
Mkt Cap: 2.78 M
Price
$1.04
Mkt Cap
2.78 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 86.20% annually over 5 years — strong growth
Negative free cash flow of -16.21 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 80.76%
Capital efficient — spends only 3.66% of revenue on capex

Growth

Revenue Growth (5Y)
86.20%
Above sector avg (1.82%)
Revenue (1Y)5.44%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-3100.50%
Op. Margin-3117.30%

Safety

Debt / Equity
N/A
Current Ratio0.77
Interest Coverage-9367.50

Valuation

PE (TTM)
-0.15
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1366 peers)
Metric Stock Sector Median
P/E -0.2 -1.5
P/B — 1.6
ROE % — -53.6
Net Margin % -3100.5 -41.5
Rev Growth 5Y % 86.2 1.8
D/E — 0.3

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q22021 -$60.90 -$44.10 +27.6%
Q12021 -$81.90 -$54.60 +33.3%
Q42020 -$78.75 -$54.60 +30.7%
Q32020 -$91.35 -$92.40 -1.2%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 5.44% Revenue Growth (3Y) 47.83%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 86.20% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 601,000.0 Net Income (TTM) -18.63 M
ROE N/A ROA -516.11%
Gross Margin N/A Operating Margin -3117.30%
Net Margin -3100.50% Free Cash Flow (TTM) -16.21 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.77
Interest Coverage -9367.50 Asset Turnover 0.17
Working Capital -1.42 M Tangible Book Value -1.32 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.15 Forward P/E N/A
P/B Ratio N/A P/S Ratio 4.63
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -582.25%
Market Cap 2.78 M Enterprise Value -96,298.0
Per Share
EPS (Diluted TTM) -8.88 Revenue / Share 0.22
FCF / Share -6.06 OCF / Share -6.05
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 3.66% FCF Conversion 86.98%
SBC-Adj. FCF -16.61 M Growth Momentum -80.76

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 601,000.0 570,000.0 275,000.0 900,000.0 50,000.0
Net Income -18.63 M -20.25 M -19.82 M -22.38 M -28.85 M
EPS (Diluted) -8.88 -43.68 -0.47 — —
Gross Profit — — — — —
Operating Income -18.74 M -22.89 M -19.91 M -22.49 M -28.33 M
EBITDA — — — — —
R&D Expenses 12.55 M 16.57 M 13.98 M 17.16 M 21.55 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2,000.0 1,000.0 2,000.0 809,000.0 489,000.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 2.60 M 3.63 M 7.98 M 9.84 M 11.70 M
Total Liabilities 5.08 M 5.94 M 2.78 M 2.43 M 14.31 M
Shareholders' Equity -2.49 M -2.31 M 5.19 M 7.41 M -26.58 M
Total Debt 0.0 26,000.0 101,000.0 175,000.0 1.13 M
Cash & Equivalents 1.11 M 1.54 M 6.39 M 8.59 M 10.60 M
Current Assets 2.53 M 3.35 M 7.48 M 9.41 M 11.29 M
Current Liabilities 5.08 M 5.92 M 2.54 M 2.26 M 13.18 M